Gene · 8570
NIH grants967
NIH grants whose papers are about the gene, through NIH's grant-paper links.
101 to 120 of 967
Download this page as JSON| Grant | Title | KHSRP papers | Newest fiscal year |
|---|---|---|---|
| R01CA262104 | Regulation of the nucleolar RNA exosome in cancer | 1 | 2025 |
| R01CA269967 | Phenotypic marker-guided development of selective antimetastasis therapeutic leads | 1 | 2025 |
| R01CA272484 | Dynamics of Notch Signaling | 1 | 2025 |
| R01CA278832 | A novel role for EZH2 in A-to-I RNA editing in prostate cancer | 1 | 2025 |
| R01CA285684 | A novel role for EZH2 in PARP regulation and PARPi-resistance in prostate cancer | 1 | 2025 |
| R01CA296618 | Exploiting a Novel DNA Repair Defect in Ewing Sarcoma | 1 | 2025 |
| R01DA054992 | Knowledge discovery and machine learning to elucidate the mechanisms of HIV activity and interaction with substance use disorder | 1 | 2025 |
| R01DK060596 | Translational control by nutrients | 1 | 2025 |
| R01DK062357 | HuR/HIF – SIRT1 Signaling Axis in Liver Transplant Rejuvenation | 1 | 2025 |
| R01DK069710 | The Role of Nuclear PARPs in Signal-Regulated Transcription | 1 | 2025 |
| R01ES013744 | Stress-Air Pollution Interactions and Adolescent Neurobehavior | 1 | 2025 |
| R01ES027778 | Mechanism for arsenic induced carcinogenesis | 1 | 2025 |
| R01ES030335 | Replication fork dynamics and repair by Rad51 paralogs after DNA alkylation | 1 | 2025 |
| R01EY026059 | The miR-183/96/182 Cluster in Pseudomonas aeruginosa-induced Keratitis | 1 | 2025 |
| R01GM083300 | Selective regulatory and biogenesis mechanisms for microRNAs | 1 | 2025 |
| R01GM085319 | Function of Sequence-specific RNA Binding Proteins | 1 | 2025 |
| R01GM086858 | New Molecular Probes For Protein Kinases | 1 | 2025 |
| R01GM119334 | Mechanisms of R-loop-Associated Genome Instability | 1 | 2025 |
| R01GM131641 | Mapping endogenous protein dynamics in living cells | 1 | 2025 |
| R01GM146257 | Homeostatic Reset as a New Therapeutic Paradigm for Slow Progression Diseases | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8570/grants?page=6